Neurotrigger
Neurotrigger develops a system designed to improve the functioning of patients suffering from facial nerve paralysis and other diseases.
Neurotrigger operates in health care, medical, medical device based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2018.
As a business in health care, medical, medical device, Neurotrigger is listed here with the public details available about it.
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) is where the company is located.
Its current recorded stage is Series_Unknown.
Total disclosed funding stands at about $1.7M.
| Sector | Health Care, Medical, Medical Device |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2018 |
| Stage | series_unknown |
| Total funding | $1,700,088 |
Website: www.neurotrigger.info
Sign in to view the contact information we hold for Neurotrigger.
Create a free account
Create a free account